Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial
PaperCitations, authors & open-access status
Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 45 citations, 2022 year and bronze oa status.
45
Citations
2022
Year
bronze
OA Status